Page 15 - Central Lab News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Axiom Presents “Unified Platforms: Key Modules and Data Considerations for Study ... Axiom Real-Time Metrics IncApril 9, 2021 GMT TEL AVIV, Israel, April 09, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at the annual Outsourcing in Clinical Trial...

Colon cancer screening could save your life More than 150,000 Americans develop colorectal cancer each year. The good news?Colorectal cancer is preventable, detectable, and if found early, treatable. By: Sponsored Content and last updated 2021-03-04 11:10:55-05 More than 150,000 Americans develop colorectal cancer each year, making it the second most common cancer related cause of death in the United States. The good news? Colorectal cancer is preventable, detectable, and if fo...

4.2.3 Wellness Hurts 4.3 Diagnostic Technology Development1 4.3.2 NAT vs. Lateral Flow 4.3.3 The Unusual Role of GPS 4.3.4 Self and Send Competition 4.4.5 The Relationship to DTC Genetic 4.4.6 The Relationship to TeleHealth 4.4.7 Sample Collection - Who Knew? 5. OTC/DTC Infectious Disease Testing Recent Developments Recent Developments - Importance and How to Use This Section Importance of These Developments FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit Stanford Developing Low-Cost...

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Single Cell Genomics Changes the Picture 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Cancer Panels & Profiles Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Biocartis Collaborating With GeneproDx, Endpoint H...

Will Personalized Companion Diagnostics become the norm for diagnostics? Companion Diagnostics are poised to revolutionize the diagnostics industry. The market is finally moving out of the lab and into the clinic. Oncology, especially immune-oncology is leading the way. And the FDA is holding the door open for this diagnostic technology of the future. But COVID-19 is impacting healthcare treatment everywhere and lowering demand for specialized cancer testing. Find out the latest outlook for thi...

4.2.3 Wellness Hurts 4.3 Diagnostic Technology Development 4.3.2 NAT vs. Lateral Flow 4.3.3 The Unusual Role of GPS 4.3.4 Self and Send Competition 4.4.5 The Relationship to DTC Genetic 4.4.6 The Relationship to TeleHealth 4.4.7 Sample Collection - Who Knew? 5. OTC/DTC Infectious Disease Testing Recent Developments Recent Developments - Importance and How to Use This Section Importance of These Developments Biohacking trend supports self testing. PerkinElmer and EverlyWell to Expand U.S....

4.2.3 Wellness Hurts 4.3 Instrumentation and Automation 4.3.2 The Shrinking Machine. 4.4 Diagnostic Technology Development 4.4.2 POCT/Self Testing as a Disruptive Force 4.4.3 The Genetics Play - One Test for All Known Infections 4.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics 5. Molecular Dx - Infectious Disease Recent Developments Recent Developments- Importance and How to Use This Section Importance of These Developments Fusion Genomics to Assess NGS-Based Respiratory Tract In...

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Impact of NGS on pricing 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Liquid Biopsy Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Liquid Biopsy NGS Panels - Diverse Test Claims CMS Colon Cancer Screening Me...

Liquid Biopsy Markets, 2025 with Impact of COVID-19 Pandemic February 02, 2021 04:43 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.coms offering. The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate, Cervical, and Other Cancers as well as breakouts by Screening/Early Detection, Diagnostic, Therapy Monitoring and Recurrence Monitor...

Global Infectious Disease Molecular Diagnostics Markets Report 2021 - Multiplex Testing Threatens Existing Assays / Test Speed Taking Centre Stage. February 02, 2021 04:38 ET | Source: Research and Markets Research and Markets Dublin, IRELAND Multiplex testing threatens existing infectious disease practice. The microbiology lab may disappear. The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for reco...